杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/14 | 1,941 | 1,941 | 1,919 | 1,934 | -4 | -0.2% | 143,700 |
2020/01/10 | 1,927 | 1,949 | 1,927 | 1,938 | +22 | +1.1% | 132,000 |
2020/01/09 | 1,913 | 1,927 | 1,909 | 1,916 | +25 | +1.3% | 112,800 |
2020/01/08 | 1,895 | 1,898 | 1,858 | 1,891 | -18 | -0.9% | 160,000 |
2020/01/07 | 1,893 | 1,918 | 1,892 | 1,909 | +28 | +1.5% | 152,500 |
2020/01/06 | 1,885 | 1,895 | 1,876 | 1,881 | -28 | -1.5% | 191,800 |
2019/12/30 | 1,924 | 1,927 | 1,904 | 1,909 | -19 | -1% | 115,700 |
2019/12/27 | 1,928 | 1,938 | 1,923 | 1,928 | +2 | +0.1% | 119,800 |
2019/12/26 | 1,901 | 1,926 | 1,901 | 1,926 | +23 | +1.2% | 115,100 |
2019/12/25 | 1,921 | 1,921 | 1,899 | 1,903 | -2 | -0.1% | 113,100 |
2019/12/24 | 1,919 | 1,926 | 1,893 | 1,905 | -7 | -0.4% | 117,300 |
2019/12/23 | 1,924 | 1,924 | 1,908 | 1,912 | -7 | -0.4% | 64,500 |
2019/12/20 | 1,931 | 1,936 | 1,911 | 1,919 | -9 | -0.5% | 75,700 |
2019/12/19 | 1,924 | 1,930 | 1,913 | 1,928 | +2 | +0.1% | 95,600 |
2019/12/18 | 1,926 | 1,933 | 1,916 | 1,926 | -5 | -0.3% | 104,100 |
2019/12/17 | 1,914 | 1,931 | 1,914 | 1,931 | +26 | +1.4% | 126,400 |
2019/12/16 | 1,900 | 1,915 | 1,897 | 1,905 | +8 | +0.4% | 118,100 |
2019/12/13 | 1,927 | 1,931 | 1,894 | 1,897 | +5 | +0.3% | 155,800 |
2019/12/12 | 1,914 | 1,914 | 1,892 | 1,892 | -20 | -1% | 132,000 |
2019/12/11 | 1,921 | 1,946 | 1,911 | 1,912 | -4 | -0.2% | 151,400 |
2019/12/10 | 1,909 | 1,927 | 1,900 | 1,916 | -1 | -0.1% | 119,500 |
2019/12/09 | 1,922 | 1,922 | 1,902 | 1,917 | +32 | +1.7% | 244,000 |
2019/12/06 | 1,862 | 1,890 | 1,861 | 1,885 | +11 | +0.6% | 170,200 |
2019/12/05 | 1,871 | 1,886 | 1,864 | 1,874 | +4 | +0.2% | 139,100 |
2019/12/04 | 1,843 | 1,872 | 1,838 | 1,870 | +12 | +0.6% | 200,900 |
2019/12/03 | 1,854 | 1,865 | 1,834 | 1,858 | -21 | -1.1% | 177,800 |
2019/12/02 | 1,870 | 1,895 | 1,870 | 1,879 | +13 | +0.7% | 140,800 |
2019/11/29 | 1,887 | 1,895 | 1,865 | 1,866 | -16 | -0.9% | 157,500 |
2019/11/28 | 1,899 | 1,899 | 1,872 | 1,882 | -7 | -0.4% | 112,400 |
2019/11/27 | 1,878 | 1,897 | 1,878 | 1,889 | +12 | +0.6% | 122,400 |
2019/11/26 | 1,888 | 1,904 | 1,875 | 1,877 | +1 | +0.1% | 241,400 |
2019/11/25 | 1,884 | 1,886 | 1,864 | 1,876 | +8 | +0.4% | 101,000 |
2019/11/22 | 1,871 | 1,890 | 1,868 | 1,868 | -6 | -0.3% | 184,800 |
2019/11/21 | 1,879 | 1,897 | 1,850 | 1,874 | -3 | -0.2% | 229,600 |
2019/11/20 | 1,861 | 1,892 | 1,857 | 1,877 | +24 | +1.3% | 201,800 |
2019/11/19 | 1,824 | 1,854 | 1,822 | 1,853 | +35 | +1.9% | 244,300 |
2019/11/18 | 1,777 | 1,819 | 1,773 | 1,818 | +48 | +2.7% | 204,600 |
2019/11/15 | 1,752 | 1,784 | 1,752 | 1,770 | +8 | +0.5% | 348,600 |
2019/11/14 | 1,779 | 1,789 | 1,760 | 1,762 | -19 | -1.1% | 333,000 |
2019/11/13 | 1,812 | 1,812 | 1,781 | 1,781 | -36 | -2% | 412,500 |
2019/11/12 | 1,817 | 1,827 | 1,806 | 1,817 | -2 | -0.1% | 243,300 |
2019/11/11 | 1,816 | 1,846 | 1,801 | 1,819 | +14 | +0.8% | 377,700 |
2019/11/08 | 1,854 | 1,868 | 1,801 | 1,805 | -49 | -2.6% | 372,900 |
2019/11/07 | 1,857 | 1,867 | 1,836 | 1,854 | +3 | +0.2% | 267,700 |
2019/11/06 | 1,882 | 1,883 | 1,833 | 1,851 | -31 | -1.6% | 344,000 |
2019/11/05 | 1,865 | 1,887 | 1,856 | 1,882 | +17 | +0.9% | 219,600 |
2019/11/01 | 1,873 | 1,880 | 1,856 | 1,865 | -38 | -2% | 244,800 |
2019/10/31 | 1,897 | 1,915 | 1,881 | 1,903 | +4 | +0.2% | 229,700 |
2019/10/30 | 1,916 | 1,928 | 1,889 | 1,899 | -15 | -0.8% | 254,500 |
2019/10/29 | 1,917 | 1,925 | 1,912 | 1,914 | +17 | +0.9% | 181,000 |
1301~
1350
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +8.8% | +99.9% | 3.49% | 9.50倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 217,600円 | +3.1% | -6.5% | 2.21% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 309,500円 | +3.0% | +27.5% | 2.58% | 19.59倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.63倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,600円 | +20.3% | - | 0.00% | 154.50倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム